Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
N4 Pharma assigns ex AstraZeneca senior research scientist to lead Nuvec, its lead vaccine delivery program.
March 8, 2018 Off

N4 Pharma assigns ex AstraZeneca senior research scientist to lead Nuvec, its lead vaccine delivery program.

By Dino Mustafić

N4 Pharma has recruited a former AstraZeneca senior research scientist to lead the Nuvec, its lead vaccine delivery program.

Sanofi, Evotec to accelerate infectious disease R&D with new open innovation platform
March 8, 2018 Off

Sanofi, Evotec to accelerate infectious disease R&D with new open innovation platform

By Dino Mustafić

Evotec and Sanofi have entered exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform, the companies said…

March 8, 2018 Off

BASF in exclusive talks with Bayer to acquire vegetable seeds business

By Dino Mustafić

BASF is in exclusive talks to acquire Bayer’s entire vegetable seeds business, operating under the global trademark Nunhems, said BASF…

Counterfeited products risk to people seeking help on the internet
March 7, 2018 Off

Counterfeited products risk to people seeking help on the internet

By Dino Mustafić

As personalised medicines become more and more prominent in today’s industry, Professor Phillipe Arnaud – Chief of Pharmacy Department at…

Novartis to advance virtual clinical trials program with expanded alliance
March 7, 2018 Off

Novartis to advance virtual clinical trials program with expanded alliance

By Dino Mustafić

Novartis aims to initiate up to 10 new clinical trials over the next three year with a leader in decentralized clinical trial…

Sonoma Pharmaceuticals nets $4.6 million after closing of public offering of common stock
March 7, 2018 Off

Sonoma Pharmaceuticals nets $4.6 million after closing of public offering of common stock

By Dino Mustafić

Sonoma Pharmaceuticals got near $4.6 million from an offering of 1,428,570 shares for price of $3.50 per share, after deducting…

Amryt expands Lojuxta reach in the Middle East with a deal with Pharon Healthcare
March 6, 2018 Off

Amryt expands Lojuxta reach in the Middle East with a deal with Pharon Healthcare

By Dino Mustafić

Amryt has expanded its market coverage for Lojuxta with an exclusive distribution agreement for Lebanon, Jordan and Syria, as it…

Pfizer names molecular immunology professor to its Board of Directors
March 6, 2018 Off

Pfizer names molecular immunology professor to its Board of Directors

By Dino Mustafić

Pfizer has appointed a professor of molecular immunology Dr. Dan R. Littman to its Board of Directors, was also appointed…

ProMIS could bring competition to Biogen’s Alzheimer drug aducanumab
March 6, 2018 Off

ProMIS could bring competition to Biogen’s Alzheimer drug aducanumab

By Dino Mustafić

ProMIS Neurosciences’s lead product candidate for Alzheimer’s disease, PMN310, showed similar ability to cross the blood brain barrier and penetrate…

Novartis’ Xoliar recommended as add-on therapy for chronic spontaneous urticaria for patients unresponsive to antihistamines
March 6, 2018 Off

Novartis’ Xoliar recommended as add-on therapy for chronic spontaneous urticaria for patients unresponsive to antihistamines

By Dino Mustafić

Novartis’ Xolair has been recommended in new global chronic urticaria guideline, the company noted Tuesday, as add-on therapy for the…

Posts pagination

Previous 1 … 3,398 3,399 3,400 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine